Mckinley Capital Management LLC Supernus Pharmaceuticals, Inc. Transaction History

Mckinley Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 07, 2019	SELL	$29.96 - $38.87 $33,015 - $42,834	-1,102 Closed	0 $0
Q4 2018 Feb 11, 2019	SELL	$30.84 - $49.51 $38,179 - $61,293	-1,238 Reduced 52.91%	1,102 $37,000
Q3 2018 Nov 08, 2018	SELL	$42.7 - $56.55 $8,497 - $11,253	-199 Reduced 7.84%	2,340 $118,000
Q2 2018 Jul 13, 2018	SELL	$44.1 - $59.85 $7,805 - $10,593	-177 Reduced 6.52%	2,539 $152,000
Q1 2018 May 04, 2018	SELL	$37.15 - $46.9 $2.82 Million - $3.56 Million	-75,870 Reduced 96.54%	2,716 $124,000

Q4 2017 Feb 08, 2018	BUY	$36.4 - $42.6 $2,002 - $2,343	55 Added 0.07%	78,586 $3.13 Million
Q3 2017 Nov 13, 2017	SELL	$36.75 - $49.65 $2.03 Million - $2.74 Million	-55,191 Reduced 41.27%	78,531 $3.14 Million
Q2 2017 Aug 14, 2017	BUY	N/A	133,722	133,722 $5.76 Million

260

57.3M

84.1K

61.2K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.38B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

Stay updated on Mckinley Capital Management LLC with notifications on news.